Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioGel Technology was a private U.S. biomaterials and drug-delivery company focused on polymer science applications in biotechnology, bioengineering, medical science, and industrial pharmacy. The company developed controlled-release systems, biodegradable microparticles and nanoparticles, biomaterials, and bioadhesive technologies, and also provided technical services to other companies using polymers in medical and pharmaceutical applications. Its known R&D included chemotherapeutic drug delivery, biodegradable PLGA/PLAGA particle systems, and a vaginal drug-delivery program supported through SBIR awards. Available evidence indicates the company was founded in 1991, operated from Indianapolis, Indiana, and was later sold in 2002. Corporate records now indicate the Indiana entity is voluntarily dissolved, so it does not appear to be an active operating company today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioGel Technology.